Expansion of IL-2-independent tumor-infiltrating lymphocytes through a feeder-free process:a preclinical study for solid tumorsOA
Expansion of IL-2-independent tumor-infiltrating lymphocytes through a feeder-free process:a preclinical study for solid tumors
Ying Zhang;Wenjia Zhuang;Huajun Jin;Jianming Xu;Sicheng Du;Rongrui Liu;Chuanhua Zhao;Juan Li;Sisi Ye;Man Zhang;Xingming Ma;Zhou He
Medical School of Chinese People's Liberation Army(PLA)General Hospital,Beijing 100853,ChinaShanghai Juncell Therapeutics,Shanghai 201802,ChinaShanghai Juncell Therapeutics,Shanghai 201802,ChinaSenior Department of Oncology,Chinese PLA General Hospital,Beijing 100853,ChinaMedical School of Chinese People's Liberation Army(PLA)General Hospital,Beijing 100853,ChinaSenior Department of Oncology,Chinese PLA General Hospital,Beijing 100853,ChinaSenior Department of Oncology,Chinese PLA General Hospital,Beijing 100853,ChinaSenior Department of Oncology,Chinese PLA General Hospital,Beijing 100853,ChinaSenior Department of Oncology,Chinese PLA General Hospital,Beijing 100853,ChinaShanghai Juncell Therapeutics,Shanghai 201802,ChinaShanghai Juncell Therapeutics,Shanghai 201802,ChinaShanghai Juncell Therapeutics,Shanghai 201802,China
Tumor-infiltrating lymphocytessolid tumorsPD-1 blockadehydroxychloroquineMHC class Ⅰ
Tumor-infiltrating lymphocytessolid tumorsPD-1 blockadehydroxychloroquineMHC class Ⅰ
《癌症生物学与医学（英文版）》 2026 (6)
910-924,15
This study was supported by the Science and Technology Innovation Action Plan of the Science and Technology Commission of Shanghai Municipality(STCSM)(Grant No.22XD1432200).
评论